학술논문
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases
Document Type
Article
Author
Source
In Urology 2005 66(5):1054-1059
Subject
Language
ISSN
0090-4295